Policies & Research

Cash Rewards for Hep C Treatment

A study is exploring whether cash rewards would motivate people to start hepatitis C treatment, and if it does, what level of payment is needed.

SAPOL Education

The Hepatitis SA Education team to deliver ongoing blood safety and viral hepatitis training and education to all operational SAPOL personnel.

Alcohol No Barrier to SVR

Research finds alcohol does not reduce chances of successful hepatitis C treatment.

Liver Cancer Control Roadmap

The elimination of hepatitis B and hepatitis C is one of the key strategies outlined in a set of guidelines addressing the alarming rise of liver cancer cases and associated …

Hepatitis C Drug Resistance

Direct-acting antiviral drugs (DAAs) to treat hepatitis C have proven to be a spectacular success, being able to cure more than 95% of people who have been living with the …

Asia-Pacific Consensus

Hep Can’t Wait is the international campaign launched by the World Hepatitis Alliance in 2021. Its aim is to highlight the social injustice and inequity caused by the current lack …

Hepatitis B Trends Falling Short

The Viral Hepatitis Mapping Project looks at geographic variations in the prevalence of viral hepatitis across Australia, as well as access to care, to identify priority areas for response. It is a …

Up to 3,000 lives saved in first year of Take-Home Naloxone program

Pharmaceutical Society of Australia calls for pharmacy participation in Take Home Naloxone program

How Hepatitis C Hides from the Immune System

Danish scientists have solved the question of how the hepatitis C virus hides in humans.

Hepatitis C Stigma and Discrimination in a Post-Cure World

Does the advent of effective hepatitis cure herald a transition to a truly ‘post-cure world'?

Treatment Barriers for Rural Aboriginal South Australians

Hepatitis C infection in indigenous communities is increasing while rate decreases in the wider community.

Creating a Hep C Home Test—with AI

The world could soon come to rely on at-home tests for many diseases thanks in part to "AI"-fuelled improvements.

DAA Treatment for Children

Chronic hepatitis C virus (HCV) infection affects around 3.5 million children worldwide, and in Australia, it’s estimated that it affects at least 4 children per million under 15 years old. …

10 Ways to Reduce Blood-Borne Viruses in Prisons

Clean needle program tops the list of strategies in a consensus stastement released by the Harm Reduction in Prisons Working Group.